Study at a glance
Can signals about microbes increase vitamin D activity in immune cells?
Researchers studied two types of human immune cells, called monocytes and macrophages, in the laboratory. They asked whether activating a signal that recognises microbes could increase vitamin D activity inside these cells. They compared stimulated and unstimulated cells and changed the vitamin D forms available to them.
How did vitamin D-related activity change in the immune cells?
Stimulation increased activity of genes for a vitamin D receptor and an enzyme that activates vitamin D. The receptor helps cells respond to active vitamin D; the enzyme converts 25-hydroxyvitamin D into the active form. Researchers also found increased activity of the gene for cathelicidin, a substance involved in killing microbes. These responses were linked to greater killing of the tested bacteria inside the cells.
Why did vitamin D availability matter?
The liquid part of blood was used to support the cells. Samples containing less 25-hydroxyvitamin D supported a weaker cathelicidin gene response. This suggests that the available starting material can limit the response. However, blood samples can differ in other substances too.
Does this cell study show that vitamin D supplements prevent infections?
The study shows a vitamin D-related defence process under specific laboratory conditions. It did not test whether supplements prevent infections in people or improve hormone function throughout the body. The results cannot be assumed to apply to every microbe, tissue or person.
Read the full article below ↓Evidence from a single verified scientific study evaluated using a fixed, auditable study-page structure.
Study classification and identity
Study type
Primary experimental study using human innate immune cells (ex vivo / in vitro stimulation with functional antimicrobial readouts)
Parent study or cohort
Not applicable
Ancillary analysis focus
Pathogen-sensing receptor activation and vitamin D pathway engagement (VDR and 1α-hydroxylase induction) as a cell-intrinsic immune program
Exposure type
Innate immune stimulation (TLR2/1 activation) in the presence of varying vitamin D substrate availability (25-hydroxyvitamin D) and pathway perturbation
Comparison or grouping structure
Stimulated vs unstimulated conditions; pathway blockade/perturbation conditions; serum with different 25-hydroxyvitamin D concentrations used to support responses
Primary endpoint category
Molecular pathway induction and functional antimicrobial response
Clinical endpoints assessed
None (no clinical outcomes; functional intracellular bacterial killing assessed under laboratory conditions)
Study purpose and framing
This study set out to test a specific mechanistic proposition about how an innate immune stimulus can recruit vitamin D biology as part of a human antimicrobial response. The authors focused on a well-defined upstream trigger, Toll-like receptor 2/1 activation, and asked whether this signal induces components of the vitamin D pathway within human macrophages. The central research question was not whether vitamin D is “good” or “bad” for infection outcomes, but whether pathogen sensing can increase local vitamin D signalling capacity through upregulation of the vitamin D receptor (VDR) and the vitamin D: activating enzyme 1α-hydroxylase (CYP27B1). The framing is therefore about vitamin D3 as an input substrate and signalling axis that can be engaged by immune activation to drive a measurable downstream programme, rather than a nutritional framing.
The outcomes are framed as a chain that must be demonstrated in sequence: receptor triggering, induction of pathway components, generation of active signalling ligand from circulating precursor, transcriptional induction of an antimicrobial effector, and a functional consequence in terms of intracellular bacterial killing. The study treats circulating 25-hydroxyvitamin D as a limiting “input” to a local activation step, and treats 1,25-dihydroxyvitamin D signalling through VDR as the operational signalling output. Importantly, the authors’ argument depends on showing that the response is not merely correlation between vitamin D status and immune markers, but that a defined immune stimulus can recruit vitamin D pathway capacity and that the pathway is required for at least one measurable antimicrobial effector response under the conditions tested.
The paper explicitly does not attempt to resolve whether differences in vitamin D exposure, supplementation, or population averages directly explain real-world infection incidence or outcomes, because it does not test clinical endpoints. It does not attempt to map all vitamin D-responsive immune genes or to define the complete set of downstream antimicrobial mechanisms across pathogens. It does not claim that the observed pathway is the only route to antimicrobial activity in human macrophages, nor that it generalises to all cell types or all contexts of immune activation. It also does not establish that vitamin D pathway induction alone is sufficient for protection independent of other immune pathways, because the experiments are constructed to test necessity within the model rather than sufficiency across clinical contexts.
Why the primary measure is used as a biological marker
A key methodological choice in the study is to treat expression of VDR and CYP27B1 as markers of local vitamin D signalling capacity inside immune cells. This is not a claim about whole-body endocrine status; it is a way of quantifying whether an immune stimulus shifts a cell toward being able to convert circulating precursor (25-hydroxyvitamin D) into the active ligand (1,25-dihydroxyvitamin D) and to respond to that ligand through receptor-mediated transcription. In this framing, circulating 25-hydroxyvitamin D acts as the upstream substrate input, while VDR and CYP27B1 represent the cellular machinery that determines whether that input can be transformed into a locally effective signalling event.
The biological relevance is that, if immune activation increases VDR and CYP27B1, then the same circulating level of precursor could yield a stronger local 1,25-dihydroxyvitamin D signal inside a macrophage than would otherwise occur. Conversely, if precursor availability is low, then induction of CYP27B1 and VDR may not translate into downstream transcriptional effects because the substrate for conversion is limiting. The interpretive guardrail here is that VDR/CYP27B1 induction indicates potential for signalling, not the realised magnitude of signalling across time in vivo. The study therefore pairs pathway markers with downstream transcriptional targets and with functional antimicrobial assays, which helps prevent overreliance on single markers.
Measurement context is crucial because vitamin D status is typically discussed at the level of circulating 25-hydroxyvitamin D, whereas intracellular signalling depends on local activation and receptor-mediated transcription. The study uses experimental stimulation conditions and serum environments to probe whether 25-hydroxyvitamin D availability constrains a downstream antimicrobial peptide induction. The key constraint is that cell culture and ex vivo conditions cannot fully reproduce the dynamic endocrine regulation of 1,25-dihydroxyvitamin D production by kidney and parathyroid hormone. Instead, the study isolates a local immune-cell activation step, using it as a defined test of the concept that immune activation can couple to vitamin D pathway activation locally.
General physiological context (not derived from this study): vitamin D3 (cholecalciferol) is typically converted to 25-hydroxyvitamin D in the liver and can be further converted to 1,25-dihydroxyvitamin D by CYP27B1. While kidney is a major endocrine site for circulating 1,25-dihydroxyvitamin D, several tissues express CYP27B1 and can generate 1,25-dihydroxyvitamin D locally, enabling intracrine or paracrine signalling. The extent to which local activation contributes to functional outcomes depends on substrate availability, enzyme expression, receptor abundance, and competing inactivation pathways, and these features can be regulated by cellular state and immune signalling.
Study overview
The study was conducted using human innate immune cell systems, focusing on monocytes/macrophages as the primary responding cell type. The experimental setting is laboratory-based, using controlled receptor stimulation to mimic pathogen recognition. The timeframe is defined by the stimulation windows used in the experiments to measure gene induction and subsequent functional consequences. Because the core claim involves a sequence of induced events, the design relies on measuring early pathway induction (VDR and CYP27B1), intermediate transcriptional changes (antimicrobial peptide gene expression), and later functional effects (intracellular bacterial killing) within the same general experimental framework.
Exposure distribution and comparisons are constructed around receptor triggering and vitamin D substrate availability. The study compares conditions with receptor stimulation versus baseline, and it examines whether downstream responses depend on the presence of vitamin D precursor and intact signalling. A key comparison described by the authors involves serum environments with different 25-hydroxyvitamin D levels, used to test whether the antimicrobial peptide response is supported or constrained by the substrate input. This is used not as a population-level clinical inference, but as an internal test of whether substrate limitation changes the magnitude of a pathway-dependent immune response in the model system.
Operational definitions in the study include: (1) pathway induction as increased expression of VDR and CYP27B1 following receptor stimulation; (2) antimicrobial response as induction of cathelicidin (a vitamin D: responsive antimicrobial peptide) as a transcriptional endpoint; and (3) functional killing as reduced intracellular survival of Mycobacterium tuberculosis in infected macrophages under stimulated conditions relative to controls. These are operational definitions suitable for a mechanistic laboratory study: they define what is measured, how the authors claim pathway coupling, and what constitutes a functional consequence under the defined experimental conditions.
Study design and measurement approach
The design is an experimental stimulation study. Human innate immune cells are exposed to a defined pathogen-sensing receptor trigger, and gene expression is measured to evaluate whether the vitamin D pathway is induced as part of the activation response. The study then connects those molecular observations to functional assays by measuring antimicrobial peptide induction and intracellular bacterial killing. Recruitment and sampling in this context refer to obtaining human immune cells and preparing them under controlled conditions; the design is not a population cohort with longitudinal follow-up but an experimental system intended to demonstrate conditional dependence of immune responses on a vitamin D signalling axis.
Laboratory measurement includes gene expression assays for VDR and CYP27B1, and transcriptional readouts for cathelicidin. The study also includes functional microbiological assays assessing intracellular viability of Mycobacterium tuberculosis within macrophages under different stimulation and signalling conditions. The pairing of molecular and functional endpoints matters because it reduces the risk that the study’s claim rests solely on proxy markers; instead, the authors attempt to show that pathway induction is accompanied by a biologically meaningful antimicrobial effect within the model.
Timing and cadence are central because receptor stimulation is expected to induce pathway components before downstream effector genes and functional outcomes can be observed. The design implies a temporal ordering: receptor triggering first, then increased capacity for local activation and receptor response, then effector induction, then altered intracellular bacterial survival. Even when exact timepoints are not the focus of the public abstract, the internal logic requires that measurements be taken at windows appropriate to capture early transcriptional induction and subsequent functional consequences. The implication is that vitamin D signalling is treated as a responsive axis that can be recruited during immune activation rather than a static baseline state.
Methodological constraints and trade-offs include at least the following. First, ex vivo/in vitro stimulation cannot reproduce the full endocrine dynamics that occur in vivo, so the conclusions are bounded to local signalling and functional consequences within the model. Second, using serum environments to vary precursor availability offers a pragmatic probe of substrate dependence, but serum differs across many variables beyond vitamin D metabolites, so the study must interpret those comparisons cautiously and avoid claiming specificity beyond what the experimental controls support. Third, antimicrobial killing assays provide functional relevance, but they remain laboratory assays that do not directly predict clinical outcomes. Fourth, the focus on particular receptor triggers and cell types means that generalisation to other immune pathways or tissues is not guaranteed by design.
Outcome hierarchy
Directly measured outcomes
Expression of VDR and CYP27B1 after innate immune receptor activation; induction of cathelicidin gene expression; intracellular killing of Mycobacterium tuberculosis under defined stimulation and signalling conditions
Outcomes explicitly not measured
Clinical infection outcomes; population-level susceptibility metrics; long-term immune memory; systemic endocrine concentrations of 1,25-dihydroxyvitamin D as a regulated hormone output
Outcomes not inferable from this study
Whether changing vitamin D exposure changes infection incidence in the general population; whether the observed mechanism dominates in vivo across infections; whether similar signalling occurs identically in non-immune tissues or across all macrophage activation contexts
Statistical analysis
The analytical approach is primarily experimental comparison across conditions rather than epidemiological modelling. The study tests whether receptor stimulation changes expression of pathway components and whether downstream effector induction and bacterial killing differ between conditions that vary in pathway integrity or substrate environment. The statistical framework is therefore aligned with hypothesis testing across experimental groups: the study is designed to support a causal claim within the model that receptor triggering leads to pathway induction and that the pathway is required for at least one downstream antimicrobial response in the tested system.
Covariates and adjustments in a laboratory study context are primarily handled through experimental controls rather than multivariable regression. Examples include unstimulated controls, stimulated conditions, and signalling perturbation or substrate limitation conditions, allowing the authors to attribute differences to the manipulated variables when controls behave as expected. Where serum from different sources is used, the study relies on the logic of substrate availability and the pattern of downstream responses; the interpretive constraint is that serum differences are not limited to vitamin D metabolites, which means the authors must frame such analyses as supportive rather than definitive proof of population causality.
Handling of missing data in experimental work typically appears as reporting of replicates, exclusion of failed assays, and presentation of representative or aggregated results across independent experiments. The design’s strength depends on reproducibility across experiments and concordance between molecular and functional readouts. Sensitivity checks, in this framework, correspond to demonstrating that pathway induction correlates with downstream effector induction and that blocking or bypassing parts of the pathway changes the downstream response in the predicted direction, without requiring inference from unobserved confounders.
Effect size framing should be interpreted as within-experiment magnitude and direction of change rather than as a population effect estimate. The uncertainty and variability arise from biological variability in human donor cells, experimental conditions, and assay variability. The statistical outputs indicate whether differences across conditions are consistent and unlikely to reflect random variation under the study’s measurement assumptions, but they do not imply clinical benefit, do not quantify risk reduction, and do not establish that the pathway operates identically across all in vivo settings. The proper inference is conditional: under the defined stimulation and substrate conditions, vitamin D pathway engagement is part of a demonstrable antimicrobial response.
Results
The primary results reported by the authors are that activation of a pathogen-sensing pathway in human macrophages increases expression of the vitamin D receptor and the vitamin D: activating enzyme 1α-hydroxylase (CYP27B1). This induction is presented as a mechanistic bridge between innate immune recognition and vitamin D signalling capacity. The study further reports induction of the antimicrobial peptide cathelicidin as a downstream transcriptional event consistent with vitamin D signalling through VDR. In other words, the study supports a directional chain: receptor activation increases cellular capacity for vitamin D signalling, and that signalling is linked to induction of a defined antimicrobial effector gene under the experimental conditions used.
Secondary results connect the molecular programme to a functional readout. The study reports that the pathway engagement is associated with enhanced killing of intracellular Mycobacterium tuberculosis in infected macrophages. This functional assay matters because it aligns the molecular findings (VDR and CYP27B1 induction; cathelicidin induction) with a measurable antimicrobial consequence. The study also describes that the capacity to induce the cathelicidin response depends on the availability of 25-hydroxyvitamin D in the serum environment supporting the cells. This is used as evidence that circulating precursor availability can be a limiting input for a locally activated intracrine response within immune cells.
The study also reports patterns consistent with attenuation under substrate-limited conditions. Specifically, sera characterised by lower 25-hydroxyvitamin D are described as less able to support cathelicidin messenger RNA induction in response to receptor activation. This pattern is used to argue that, even if receptor stimulation induces VDR and CYP27B1, the downstream effector induction can be constrained if the substrate input is insufficient. The design implication is not that serum differences prove population susceptibility, but that the experimental system behaves in a manner consistent with substrate limitation, which is coherent with the proposed intracrine activation model.
Robustness considerations in the study are tied to internal consistency across the chain of evidence. The authors report concordance between receptor triggering, pathway gene induction, downstream effector induction, and functional antimicrobial consequence. Study-reported caveats include the general caution that ex vivo responses do not directly translate to clinical outcomes and that serum comparisons can be influenced by variables beyond vitamin D metabolites. The interpretive centre of gravity therefore rests on the controlled stimulation and pathway dependence within the model, while the serum observations provide supportive context for the “input substrate” concept rather than standing alone as population inference.
Measurement considerations and limitations
Measurement error and uncertainty can arise at multiple points: variability in human donor immune cell responsiveness, assay variability in gene expression measurement, and variability in functional bacterial killing assays. A key interpretive distinction is between biological variability (real differences between donors and conditions) and technical variability (measurement noise). The study’s design partially addresses this by linking multiple readouts along a hypothesised pathway chain; when several linked outcomes shift coherently, it strengthens the case that the observed effects are not purely measurement noise. However, the study still depends on the quality of controls and the reproducibility of responses across experiments.
Representativeness and generalisability are limited by the experimental system. The study uses specific innate immune triggers and a defined pathogen model, which means the conclusions are conditional on those contexts. The results support that human macrophages can recruit vitamin D signalling components during certain innate immune activations, but they do not establish the magnitude or prevalence of this mechanism across all infections, across all macrophage activation states, or across all human tissues. Additionally, laboratory infection models simplify the in vivo environment, so the findings should be treated as mechanistic evidence rather than clinical prediction.
Confounding and reverse causality are not the primary threats in a controlled stimulation experiment, but they matter in the serum comparison observations. When the study uses sera that differ in 25-hydroxyvitamin D levels, those sera may also differ in other factors that could influence immune responses. The study’s logic is that low 25-hydroxyvitamin D correlates with reduced capacity to induce cathelicidin under the stimulation conditions, supporting the substrate-limitation concept. The limitation is that this does not isolate vitamin D metabolites as the only driver of the difference unless additional controls demonstrate specificity. Therefore, the serum observations are best interpreted as consistent with substrate dependence, not as definitive proof of population causality or susceptibility.
Generalisability and population context
The study is most applicable to questions about whether vitamin D biology can function as a signalling axis inside immune cells in response to innate immune triggers. It provides evidence that human macrophages can increase local vitamin D signalling capacity and that downstream antimicrobial peptide induction and bacterial killing can depend on that axis. This makes it relevant to the physiology page topic of vitamin D3 as an input signal: the “input” is not only endocrine in the classical sense, but also substrate availability for locally activated signalling events that are coupled to cell state and immune activation.
Boundaries where extrapolation is not valid include the following. The study does not justify extrapolation to clinical outcomes such as reduced infection rates, faster recovery, or population-level protection. It does not justify extrapolation to all pathogens or all immune cells; the demonstrated response is tied to the stimuli and cells tested. It does not justify extrapolation to the endocrine system as a whole; the study is not measuring systemic hormonal regulation or kidney-driven endocrine outputs. It also does not justify extrapolation to non-immune tissues, even though those tissues may express vitamin D pathway components, because the immune-trigger coupling and functional outputs may differ substantially across tissue contexts.
Context-specific factors flagged by the study as limiting transferability are primarily the experimental nature of the work and the conditional dependence on substrate availability. The study uses controlled conditions that allow the pathway to be observed in a traceable manner; in vivo, multiple regulatory systems and competing pathways operate simultaneously. The study’s serum observations highlight that differences in precursor availability can modulate downstream responses in the model, but they do not establish the distribution of such limitations in real-world settings. Therefore, the study supports a physiological possibility and a mechanistic pathway, while explicitly leaving broader questions of magnitude, prevalence, and clinical impact to other study designs.
Mechanistic inference boundary
This study provides mechanistic evidence within a laboratory model that links innate immune receptor activation to vitamin D pathway induction and to a downstream antimicrobial response. Within the model, the directionality is plausible because the upstream trigger is controlled and the downstream pathway components and functional readouts move in a coherent sequence. However, the study does not establish that the same chain is the dominant mechanism of antimicrobial defence in vivo, nor that it operates equivalently across all immune activation contexts. The mechanistic inference is therefore bounded to: “under these stimulation conditions, a vitamin D signalling axis is engaged and is required for a measurable antimicrobial programme in the system tested.”
What cannot be concluded includes: that vitamin D3 intake or sun exposure will predictably produce the same antimicrobial effect in real-world infections; that increasing circulating 25-hydroxyvitamin D will necessarily increase intracellular killing across pathogens; that cathelicidin induction is sufficient to account for all observed killing; or that the pathway engagement implies net benefit across immune responses independent of context. The study does not resolve whether other antimicrobial pathways could compensate under different conditions, or whether the pathway behaves differently in chronic disease states, co-infections, or different immune cell differentiation states.
A critical separation in this physiology context is between signalling capacity and downstream outcomes. The study demonstrates that immune activation can increase signalling capacity (VDR and CYP27B1 induction) and that a downstream effector (cathelicidin) and a functional readout (intracellular bacterial killing) can follow under supportive conditions. But the presence of signalling capacity does not imply a clinical outcome, and a signalling event in a cell does not imply whole-system endocrine benefit. The correct inference boundary is that vitamin D3-related metabolites can serve as inputs into cell-intrinsic signalling programmes under certain immune conditions, with measurable downstream effects in the model, while broader physiological outcomes remain outside the scope of this single study.
Interpretation within vitamin D physiology
This study is directly relevant to understanding vitamin D3 as an input signal because it shows a route by which a circulating precursor pool (25-hydroxyvitamin D, derived ultimately from vitamin D3 input and subsequent metabolism) can become functionally meaningful inside a tissue cell through local activation and receptor-mediated transcription. In the study’s model, an immune trigger increases the cell’s capacity to convert precursor into active ligand and to respond via VDR, turning substrate availability into a conditional signalling event. The physiology implication is that vitamin D biology can operate not only as a systemic endocrine axis but also as a locally engaged intracrine programme whose strength depends on both cellular state (immune activation) and substrate input (precursor availability). This is a constrained, mechanistic interpretation aligned with what the study measured.
For relevant physiology background, see Understanding Vitamin D3.
For the concise version of this analysis, see Vitamin D3 as an Input Signal in Endocrine and Intracrine Systems: Study Summary.
Interpretation
A supported interpretation of this study is that innate immune activation can recruit vitamin D signalling machinery within human macrophages in a way that is functionally relevant under the tested conditions. The evidence rests on a linked set of observations: receptor triggering increases expression of pathway components (VDR and CYP27B1), downstream vitamin D: responsive effector expression is induced (cathelicidin), and intracellular bacterial killing is enhanced in a manner consistent with pathway engagement. In the physiology framing, this supports the concept that vitamin D3-derived metabolite pools can act as inputs into cell-intrinsic signalling programmes, and that those programmes can be conditionally activated by upstream immune signals.
Boundary restatement is essential. This study does not claim that vitamin D status alone determines infection risk, nor does it establish clinical efficacy of altering vitamin D exposure. It does not quantify the contribution of this pathway relative to other antimicrobial systems in vivo. It does not demonstrate that the same mechanism is present in all immune cells, tissues, or infections. It also does not demonstrate that population differences in 25-hydroxyvitamin D necessarily translate into clinical susceptibility, because the study’s serum observations are supportive within an experimental context rather than a comprehensive causal population analysis.
Measured versus contextual separation: the study measured pathway induction (VDR and CYP27B1 expression changes), effector induction (cathelicidin gene expression), and functional bacterial killing under defined experimental conditions. Any discussion of endocrine versus intracrine framing, substrate limitation concepts, or broader physiological roles is contextual interpretation that must remain consistent with those measured outputs and must not extend into untested claims. In this sense, the study functions as an auditable demonstration that vitamin D signalling capacity can be dynamically regulated by immune activation and that downstream antimicrobial effects can be observed when substrate availability supports the pathway, without implying that this automatically predicts clinical outcomes.
Primary source and publication details
Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al.
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.
Science. 2006.
DOI: 10.1126/science.1123933
https://pubmed.ncbi.nlm.nih.gov/16497887/
For deeper pathway background only see: Vitamin D Activation, Vitamin D Metabolism at the Cellular Level, Vitamin D Receptors.
Related reading
Vitamin D3 as an Input Signal in Endocrine and Intracrine Systems: Study Summary
Concise summary of a verified scientific study on vitamin D3 as an endocrine and intracrine signalling input, with clear interpretation boundaries and a link to the full evidence review.
Read more →Association of Vitamin D Supplementation with VDR and CAMP Expression and Ulcer Healing in Diabetic Foot Infection Involving Biofilm-Forming Bacteria: An Exploratory Prospective Cohort Study
This study investigated the association between vitamin D supplementation, the vitamin D: VDR: CAMP: LL-37 pathway, and ulcer healing in DFIs involving biofilm-forming bacteria.
Original paper ↗Read more →Convergence of IL-1β and VDR Activation Pathways in Human TLR2/1-Induced Antimicrobial Responses
Antimicrobial effector mechanisms are central to the function of the innate immune response in host defense against microbial pathogens.
Original paper ↗Read more →Mycobacterium avium paratuberculosis Infection Suppresses Vitamin D Activation and Cathelicidin Production in Macrophages through Modulation of the TLR2-Dependent p38/MAPK-CYP27B1-VDR-CAMP Axis
Background: Vitamin D plays a vital role in modulating both innate and adaptive immune systems.
Original paper ↗Read more →Search for Potential VDR/Partner Composite Elements in Regulatory DNA of Genes Associated with Respiratory Infections and Atopic Diseases
Vitamin D deficiency is associated with the risk of atopic diseases and respiratory infections.
Original paper ↗Read more →The vitamin D receptor and inducible nitric oxide synthase associated pathways in acquired resistance to Cooperia oncophora infection in cattle
Compared to primary infection, reinfection resulted in a marked reduction in worm establishment.
Original paper ↗Read more →Vitamin D receptor, vitamin D binding protein and CYP27B1 single nucleotide polymorphisms and susceptibility to viral infections in infants
As compared to controls, ΤaqI was more frequent in infants with viral infection compared to controls (p = 0.03, OR 1.96, 95% CI 1.1 to 3.58).
Original paper ↗Read more →Downregulation of serum vitamin D receptor level, serum 25-hydroxyvitamin D, and association of vitamin D receptor gene polymorphisms ApaI and TaqI with obesity in the Bangladeshi population
The purpose of our study was to investigate the association between two single-nucleotide polymorphisms (SNPs) (Apal, rs7975232, and Taql, rs731236) of the VDR gene and the risk of obesity in the Bangladeshi population.
Original paper ↗Read more →Plasma 25-Hydroxyvitamin D Level and VDR Gene Single Nucleotide Polymorphism rs2228570 Influence on COVID-19 Susceptibility among the Kazakh Ethnic Group: A Pilot Study
We compared the 25(OH)D plasma levels and concluded that the COVID-19-positive group values (25.17 ng/mL ± 16.65) were statistically lower (p = 0.0114) compared to the COVID-19-negative ones (35.58 ng/mL ± 20.67).
Original paper ↗Read more →Plasma 25-Hydroxyvitamin D Levels and VDR Gene Expression in Peripheral Blood Mononuclear Cells of Leukemia Patients and Healthy Subjects in Central Kazakhstan
A similar difference was observed in both younger (60 years old) participants, though there was no association between 25(OH)D concentration and age within the patient group.
Original paper ↗Read more →Polymorphism of VDR Gene and the Sensitivity of Human Leukemia and Lymphoma Cells to Active Forms of Vitamin D
Therefore, the study aimed to determine the use of an active form of vitamin D3 calcitriol and its analog tacalcitol as an anticancer drug.
Original paper ↗Read more →Relationship Between Vitamin D Receptor Gene BsmI Polymorphism and 25-Hydroxyvitamin D Total Levels in Slovak Postmenopausal Women with Reduced Bone Mineral Density
The aim of the study was to investigate the relationship between the VDR gene BsmI polymorphism and 25(OH)D levels in Slovak postmenopausal women.
Original paper ↗Read more →Therapeutic Potential of a Novel Vitamin D3 Oxime Analogue, VD1-6, with CYP24A1 Enzyme Inhibitory Activity and Negligible Vitamin D Receptor Binding
However, in silico docking experiments demonstrated that VD1-6 was predicted to have superior binding to CYP24A1, when compared to that of 1,25(OH)2D3.
Original paper ↗Read more →Variants in the VDR Gene May Influence 25(OH)D Levels in Type 1 Diabetes Mellitus in a Brazilian Population
This study aimed to evaluate the association of four variants in the VDR gene (rs7975232, rs1544410, rs731236, and rs2228570) with T1DM risk and vitamin D levels within a population from North Region, Brazil, as well as the influence of genomic ancestry on T1DM.
Original paper ↗Read more →Vitamin D Genetics Beyond Serum 25(OH)D: VDR rs2228570 (FokI) Polymorphism, Inflammation, and Quality of Life in Orthopedic Patients
This study investigated the rs2228570 (FokI) variant in relation to inflammatory, hematologic, and patient-reported outcomes in orthopedic patients.
Original paper ↗Read more →Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune disease
We aimed to investigate VDR binding in primary CD4+ cells from healthy volunteers.
Original paper ↗Read more →Circulating 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Concentrations and Postoperative Infections in Cardiac Surgical Patients: The CALCITOP-Study
In 3,340 consecutive cardiac surgical patients, we investigated the association of circulating 25-hydroxyvitamin D (25OHD; indicator of nutritional vitamin D status) and 1,25-dihydroxyvitamin D (1,25[OH]2D; active vitamin D hormone) with nosocomicial infections.
Original paper ↗Read more →Diverse Effects of Combinations of Maternal-Neonatal VDR Polymorphisms and 25-Hydroxyvitamin D Concentrations on Neonatal Birth Anthropometry: Functional Phenocopy Variability Dependence, Highlights the Need for Targeted Maternal 25-Hydroxyvitamin D Cut-Offs during Pregnancy
The aim of this study was to evaluate the combined effect of maternal and neonatal VDR polymorphisms (ApaI, TaqI, BsmI, FokI, Tru9I) and different maternal and neonatal 25(OH)D cut-offs on neonatal birth anthropometry.
Original paper ↗Read more →Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis
We here investigated if low vitamin D levels might be associated with prognosis, inflammation and infectious complications in patients with cirrhosis.
Original paper ↗Read more →Low cord-serum 25-hydroxyvitamin D levels are associated with poor lung function performance and increased respiratory infection in infancy
The aim of this study was to investigate the impact of perinatal vitamin D levels on respiratory function and disease outcome in infancy.
Original paper ↗Read more →Serum 25-hydroxyvitamin D levels in patients with Granulomatosis with Polyangiitis: association with respiratory infection
Thirty-two granulomatosis with polyangiitis patients were evaluated in the winter/spring, and the same patients (except 5) were evaluated in summer/autumn (n=27).
Original paper ↗Read more →Original sources
https://pubmed.ncbi.nlm.nih.gov/16497887/
https://pubmed.ncbi.nlm.nih.gov/16497887/.
Publication details
https://pubmed.ncbi.nlm.nih.gov/16497887/